GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Highnoon Laboratories Ltd (KAR:HINOON) » Definitions » EV-to-Revenue

Highnoon Laboratories (KAR:HINOON) EV-to-Revenue : 1.75 (As of Jun. 03, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Highnoon Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Highnoon Laboratories's enterprise value is ₨44,628 Mil. Highnoon Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₨25,514 Mil. Therefore, Highnoon Laboratories's EV-to-Revenue for today is 1.75.

The historical rank and industry rank for Highnoon Laboratories's EV-to-Revenue or its related term are showing as below:

KAR:HINOON' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.77   Med: 1.74   Max: 4.79
Current: 1.75

During the past 12 years, the highest EV-to-Revenue of Highnoon Laboratories was 4.79. The lowest was 0.77. And the median was 1.74.

KAR:HINOON's EV-to-Revenue is ranked better than
61.46% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs KAR:HINOON: 1.75

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Highnoon Laboratories's stock price is ₨912.92. Highnoon Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₨475.14. Therefore, Highnoon Laboratories's PS Ratio for today is 1.92.


Highnoon Laboratories EV-to-Revenue Historical Data

The historical data trend for Highnoon Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Highnoon Laboratories EV-to-Revenue Chart

Highnoon Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 1.65 1.38 1.31 1.82

Highnoon Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.66 1.47 1.82 1.76

Competitive Comparison of Highnoon Laboratories's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Highnoon Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Highnoon Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Highnoon Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Highnoon Laboratories's EV-to-Revenue falls into.


;
;

Highnoon Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Highnoon Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=44627.869/25513.534
=1.75

Highnoon Laboratories's current Enterprise Value is ₨44,628 Mil.
Highnoon Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨25,514 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Highnoon Laboratories  (KAR:HINOON) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Highnoon Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=912.92/475.143
=1.92

Highnoon Laboratories's share price for today is ₨912.92.
Highnoon Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨475.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Highnoon Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Highnoon Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Highnoon Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.

Highnoon Laboratories Headlines

No Headlines